SEVEN BIOSCIENCES, INC.

Biotech · Private

Patented GPCR conformer sensor platform enabling real-time imaging of receptor pharmacodynamics for high-throughput drug discovery.

Grants
$446K
2 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantNational Science Foundation · Phase I · STTR Phase I: A kinetic and conformation based platform for targeting G-protein coupled receptors$225,000
Federal grantDepartment of Health and Human Services · Phase I · Next generation GPCR drug discovery$221,400
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2722MIDWEST BIOPROCESSING CENTER LLC——
2723Accuronix Therapeutics Inc——
2724Alveus Pharma——
2725SEVEN BIOSCIENCES, INC.——
2726DOTQUANT LLC——
2727Metaphore Biotechnologies——
2728Cellarity——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.